Item 9 Labs Corp
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It operates through Cultivation, Franchising, and Corporate segments. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies thr… Read more
Item 9 Labs Corp (INLB) - Total Liabilities
Latest total liabilities as of June 2023: $59.37 Million USD
Based on the latest financial reports, Item 9 Labs Corp (INLB) has total liabilities worth $59.37 Million USD as of June 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Item 9 Labs Corp - Total Liabilities Trend (2010–2022)
This chart illustrates how Item 9 Labs Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Item 9 Labs Corp Competitors by Total Liabilities
The table below lists competitors of Item 9 Labs Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
HIGHLIGHT COMMUNICA (HLG.SG)
STU:HLG
|
Germany | €448.23 Million |
|
Derimod Konfeksiyon Ayakkabi Deri Sanayi ve Ticaret AS
IS:DERIM
|
Turkey | TL254.20 Million |
|
REALTECH - Dusseldorf Stock Exchang
DU:RTC
|
Germany | €2.09 Million |
|
SPORTING
MU:SCG
|
Germany | €353.42 Million |
Liability Composition Analysis (2010–2022)
This chart breaks down Item 9 Labs Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Item 9 Labs Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Item 9 Labs Corp (2010–2022)
The table below shows the annual total liabilities of Item 9 Labs Corp from 2010 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-09-30 | $48.82 Million | +58.99% |
| 2021-09-30 | $30.71 Million | +142.78% |
| 2020-09-30 | $12.65 Million | +77.20% |
| 2019-09-30 | $7.14 Million | +697.32% |
| 2018-09-30 | $895.23K | -61.72% |
| 2017-09-30 | $2.34 Million | +8.16% |
| 2016-09-30 | $2.16 Million | -57.58% |
| 2015-09-30 | $5.10 Million | +62.08% |
| 2014-09-30 | $3.14 Million | -6.96% |
| 2013-09-30 | $3.38 Million | -1.28% |
| 2012-09-30 | $3.42 Million | +4828.65% |
| 2011-09-30 | $69.47K | +61.15% |
| 2010-09-30 | $43.11K | -- |